Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy

Hypertension. 2015 Feb;65(2):335-44. doi: 10.1161/HYPERTENSIONAHA.114.04467. Epub 2014 Dec 8.

Abstract

Activation of Wnt signaling results in maladaptive cardiac remodeling and cardiomyopathy. Recently, calcium/calmodulin-dependent protein kinase II (CaMKII) was reported to be a pivotal participant in myocardial remodeling. Because CaMKII was suggested as a downstream target of noncanonical Wnt signaling, we aimed to elucidate the role of CaMKII in dishevelled-1-induced cardiomyopathy and the mechanisms underlying its function. Dishevelled-1-induced cardiomyopathy was reversed by deletion of neither CaMKIIδ nor CaMKIIγ. Therefore, dishevelled-1-transgenic mice were crossed with CaMKIIδγ double-knockout mice. These mice displayed a normal cardiac phenotype without cardiac hypertrophy, fibrosis, apoptosis, or left ventricular dysfunction. Further mechanistic analyses unveiled that CaMKIIδγ couples noncanonical Wnt signaling to histone deacetylase 4 and myosin enhancer factor 2. Therefore, our findings indicate that the axis, consisting of dishevelled-1, CaMKII, histone deacetylase 4, and myosin enhancer factor 2, is an attractive therapeutic target for prevention of cardiac remodeling and its progression to left ventricular dysfunction.

Keywords: Wnt signaling pathway; calcium-calmodulin-dependent protein kinase type 2; cardiomyopathies; dishevelled proteins; histone deacetylase 4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / physiology*
  • Animals
  • Apoptosis
  • Benzylamines / pharmacology
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / deficiency
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / physiology*
  • Dishevelled Proteins
  • Fibrosis
  • Heart Failure / enzymology*
  • Heart Failure / physiopathology
  • Heart Failure / prevention & control
  • Histone Deacetylases / physiology*
  • Hypertrophy, Left Ventricular / diagnostic imaging
  • Hypertrophy, Left Ventricular / enzymology*
  • Hypertrophy, Left Ventricular / genetics
  • Hypertrophy, Left Ventricular / physiopathology
  • MAP Kinase Signaling System
  • MEF2 Transcription Factors / physiology
  • Mice
  • Mice, Knockout
  • Myocardium / pathology
  • Phenotype
  • Phosphoproteins / physiology*
  • Protein Kinase C / physiology
  • Sulfonamides / pharmacology
  • Ultrasonography
  • Ventricular Dysfunction, Left / enzymology*
  • Ventricular Dysfunction, Left / genetics
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Remodeling
  • Wnt Proteins / physiology*
  • Wnt Signaling Pathway / physiology*
  • beta Catenin / physiology

Substances

  • Adaptor Proteins, Signal Transducing
  • Benzylamines
  • Dishevelled Proteins
  • Dvl1 protein, mouse
  • MEF2 Transcription Factors
  • Mef2a protein, mouse
  • Mef2b protein, mouse
  • Phosphoproteins
  • Sulfonamides
  • Wnt Proteins
  • beta Catenin
  • KN 93
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Hdac5 protein, mouse
  • Histone Deacetylases